Orbimed Advisors - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 124 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2021$54,241,000
-9.0%
5,501,1440.0%0.51%
-2.9%
Q4 2020$59,632,000
+26.3%
5,501,144
+20.0%
0.52%
-12.0%
Q3 2020$47,219,000
-31.3%
4,584,344
+39.3%
0.59%
-38.7%
Q2 2020$68,711,000
+103.8%
3,290,744
-4.6%
0.97%
+70.5%
Q1 2020$33,713,000
-32.6%
3,450,644
-20.5%
0.57%
-20.6%
Q4 2019$50,022,000
+128.7%
4,342,190
+8.2%
0.71%
+72.0%
Q3 2019$21,871,000
-6.2%
4,012,969
+104.7%
0.42%
+15.0%
Q2 2019$23,307,000
+257.8%
1,960,200
+57.7%
0.36%
+257.4%
Q1 2019$6,514,0001,243,2000.10%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2021
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,043,212$46,578,00047.83%
Soleus Capital Management, L.P. 342,800$3,949,0003.81%
ACUTA CAPITAL PARTNERS, LLC 1,322,500$15,235,0003.77%
RTW INVESTMENTS, LP 6,386,607$73,574,0002.78%
Ghost Tree Capital, LLC 1,175,000$13,536,0002.58%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$5,530,0002.48%
VHCP Management III, LLC 946,234$10,901,0002.16%
Avoro Capital Advisors LLC 5,250,000$60,480,0001.78%
VHCP Management II, LLC 383,620$4,419,0001.16%
Rhenman & Partners Asset Management AB 650,000$7,488,0000.82%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders